Publication
Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency
| dc.contributor.author | Bacalhau, S | |
| dc.contributor.author | Freitas, C | |
| dc.contributor.author | Valente, R | |
| dc.contributor.author | Barata, D | |
| dc.contributor.author | Neves, C | |
| dc.contributor.author | Schäfer, K | |
| dc.contributor.author | Lubatschofski, A | |
| dc.contributor.author | Schulz, A | |
| dc.contributor.author | Farela Neves, J | |
| dc.date.accessioned | 2013-11-25T13:45:55Z | |
| dc.date.available | 2013-11-25T13:45:55Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | In high-burden countries, Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine is administered in newborn to prevent severe Mycobacterium tuberculosis infection. Because life-threatening disseminated BCG disease may occur in children with primary immunodeficiency, vaccination strategy against tuberculosis should be redefined in non-high-burden countries. We report the case of a patient with X-linked severe combined immunodeficiency (SCID) who developed disseminated BCG disease, highlighting the specific strategies adopted. | por |
| dc.identifier.citation | Case Rep Med. 2011, Article ID 527569 | por |
| dc.identifier.uri | http://hdl.handle.net/10400.17/1566 | |
| dc.language.iso | eng | por |
| dc.publisher | Hindawi Publishing Corporation | por |
| dc.subject | BCG | por |
| dc.subject | Recém-Nascido | por |
| dc.subject | Imunodeficiência Combinada Severa | por |
| dc.subject | HDE UCI PED | por |
| dc.subject | HDE INF PED | por |
| dc.title | Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 5 | por |
| oaire.citation.startPage | 1 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | article | por |